Discuss the opportunistic infections in HIV in relation to CD4 count, including the CNS complications of AIDS.
Principle
Opportunistic infections (OIs) occur as cell-mediated immunity fails, and the CD4 count predicts which infections become possible — making it the single most useful guide to differential diagnosis in a symptomatic HIV patient. Knowing the CD4 threshold for each infection is the key examination skill.
Opportunistic Infections BY CD4 Count
| CD4 count (cells/µL) | Infections and conditions |
|---|---|
| > 500 | Acute retroviral syndrome, persistent generalised lymphadenopathy; same infections as the general population; tuberculosis can occur at ANY CD4 count |
| 200–500 | Pulmonary tuberculosis, bacterial pneumonia (pneumococcal), herpes zoster, oral candidiasis, oral hairy leucoplakia (EBV), Kaposi's sarcoma, seborrhoeic dermatitis, ITP |
| 100–200 | *Pneumocystis jirovecii* pneumonia (PCP), disseminated and extrapulmonary tuberculosis, chronic cryptosporidiosis and isosporiasis, oesophageal candidiasis, progressive multifocal leukoencephalopathy |
| 50–100 | Cerebral toxoplasmosis, cryptococcal meningitis, oesophageal candidiasis, disseminated histoplasmosis and penicilliosis, primary CNS lymphoma, HIV wasting, HIV encephalopathy |
| < 50 | CMV retinitis and colitis, disseminated Mycobacterium avium complex (MAC), CNS lymphoma, disseminated fungal infection |
Learn three CD4 thresholds and you can answer most questions in this area: 200 for PCP, 100 for toxoplasmosis and cryptococcus, and 50 for CMV and MAC. And remember the exception that matters most in India — tuberculosis occurs at any CD4 count, including in patients with normal counts, so it must never be excluded on the basis of preserved immunity.
Major Opportunistic Infections
1. Tuberculosis — the commonest OI and leading cause of death in India
Presentation is atypical at low CD4 counts: less cavitation, more lower zone and miliary disease, lymphadenopathy and extrapulmonary involvement, and sputum smears more often negative. CBNAAT is the first-line test. ATT is started first, with ART added after 2–8 weeks (earlier for very low CD4, later for TB meningitis because of IRIS risk). Rifampicin interacts with protease inhibitors and dolutegravir, requiring dose adjustment or substitution with rifabutin.
2. *Pneumocystis jirovecii* pneumonia (PCP) — CD4 < 200
- Subacute onset over weeks of exertional dyspnoea, dry cough and fever, with a characteristically normal chest examination despite marked hypoxia
- desaturation on exertion is a valuable bedside sign. Chest X-ray shows bilateral perihilar interstitial ("bat-wing") infiltrates, or may be normal
- HRCT shows ground-glass change.
- Raised LDH supports the diagnosis. Confirm by induced sputum or bronchoalveolar lavage with silver or immunofluorescence staining or PCR. Treat with high-dose co-trimoxazole, adding corticosteroids when there is significant hypoxia — steroids reduce mortality in moderate to severe disease.
3. Cerebral toxoplasmosis — CD4 < 100
- Reactivation of latent *Toxoplasma gondii*.
- Subacute headache, fever, focal neurological deficit, seizures and altered consciousness. CT/MRI shows multiple ring-enhancing lesions with surrounding oedema, favouring the basal ganglia and grey-white junction.
- Toxoplasma serology (IgG) is usually positive — a negative IgG makes the diagnosis unlikely. Treat with pyrimethamine plus sulphadiazine with folinic acid (or high-dose co-trimoxazole)
- clinical and radiological improvement within 10–14 days confirms the diagnosis empirically, and failure to respond should prompt biopsy for lymphoma.
4. Cryptococcal meningitis — CD4 < 100
- Insidious onset over weeks of headache, fever, malaise and vomiting, with meningism frequently ABSENT and few focal signs — the presentation is often deceptively bland.
- Raised intracranial pressure is the major cause of death. Diagnose by CSF India ink stain (encapsulated yeasts), cryptococcal antigen (CrAg) in CSF and serum — highly sensitive and the test of choice, and fungal culture. CSF shows a modest lymphocytic pleocytosis with high opening pressure. Treat with induction (amphotericin B with flucytosine), consolidation (fluconazole) and maintenance, and — critically — repeated therapeutic lumbar punctures to control intracranial pressure.
- ART is deferred by 4–6 weeks because of the high risk of fatal IRIS.
5. Cytomegalovirus — CD4 < 50
CMV retinitis — painless progressive visual loss with floaters; fundoscopy shows "pizza-pie" retinitis with haemorrhage and exudate along vessels. It is sight-threatening and needs urgent ophthalmological assessment. Also causes colitis (diarrhoea, bleeding), oesophagitis and encephalitis. Treat with ganciclovir, valganciclovir or foscarnet.
6. Disseminated Mycobacterium avium complex — CD4 < 50
Fever, night sweats, weight loss, diarrhoea, hepatosplenomegaly, anaemia and raised alkaline phosphatase. Diagnose by blood culture for mycobacteria. Treat with clarithromycin plus ethambutol with or without rifabutin.
7. Chronic diarrhoea — *Cryptosporidium*, *Isospora (Cystoisospora) belli*, *Cyclospora*, microsporidia, MAC, CMV — diagnosed on modified acid-fast staining of stool. Effective ART with immune reconstitution is the definitive treatment for cryptosporidiosis; co-trimoxazole treats isosporiasis.
8. Fungal and other: oesophageal candidiasis (dysphagia and odynophagia — treat with fluconazole), disseminated histoplasmosis and talaromycosis (penicilliosis), and visceral leishmaniasis (kala-azar) with HIV co-infection, which is an important and difficult problem in parts of India.
CNS Complications of AIDS
| Condition | CD4 | Key features | Imaging |
|---|---|---|---|
| Cerebral toxoplasmosis | < 100 | Subacute focal deficit, seizures, fever | Multiple ring-enhancing lesions, basal ganglia |
| Primary CNS lymphoma | < 50 | Slower onset, no fever, EBV DNA in CSF | Single (or few) periventricular lesion, homogeneous or ring enhancement; PET/thallium avid |
| Cryptococcal meningitis | < 100 | Insidious headache, raised ICP, minimal meningism | Usually normal; may show hydrocephalus |
| Progressive multifocal leukoencephalopathy (PML) | < 200 | JC virus; progressive focal deficits, visual field loss, cognitive decline; no fever | Multifocal white matter lesions, NO enhancement, NO mass effect |
| HIV-associated neurocognitive disorder / HIV encephalopathy | < 200 | Subcortical dementia — apathy, poor concentration, slowed movement | Cerebral atrophy and diffuse white matter change |
| Tuberculous meningitis / tuberculoma | Any | Subacute meningitis, cranial nerve palsies | Basal meningeal enhancement, hydrocephalus, ring-enhancing tuberculoma |
| CMV encephalitis / polyradiculitis | < 50 | Delirium, cranial neuropathy, cauda equina syndrome | Periventricular enhancement |
Distinguishing toxoplasmosis from primary CNS lymphoma is a recurring clinical and examination problem: toxoplasmosis typically gives multiple lesions with positive serology and responds to a 2-week empirical trial of anti-toxoplasma therapy; lymphoma gives a solitary periventricular lesion with EBV DNA in CSF, is thallium/PET avid, and does not respond — at which point stereotactic biopsy is indicated.
Prophylaxis
| Infection | Indication | Agent |
|---|---|---|
| PCP and toxoplasmosis | CD4 < 200 (or oral candidiasis, or WHO stage 3/4) | Co-trimoxazole — also protects against isosporiasis and some bacterial infections |
| Tuberculosis | All PLHIV after excluding active TB | TB preventive therapy (isoniazid-based or short-course rifapentine regimens) |
| Cryptococcal disease | CD4 < 100 with positive serum CrAg | Pre-emptive fluconazole |
| MAC | CD4 < 50 (where ART is unavailable or delayed) | Azithromycin |
Prophylaxis can be stopped once ART produces sustained immune reconstitution above the relevant threshold. The single most effective prophylaxis against all opportunistic infections is effective, adherent antiretroviral therapy.
Prophylaxis thresholds, drug regimens and the timing of ART initiation relative to each OI — confirm against current NACO and WHO guidance before printing.
All questions in HIV and AIDS
- Q1Discuss the aetiology, transmission, natural history, clinical features, diagnosis and staging of HIV infection. ★
- Q2Discuss the opportunistic infections in HIV in relation to CD4 count, including the CNS complications of AIDS. ★
- Q3Discuss antiretroviral therapy — classes of drugs, first-line regimens, adverse effects, monitoring and treatment failure. ★
- SN1Write a short note on post-exposure prophylaxis for HIV.
- SN2Write a short note on immune reconstitution inflammatory syndrome.
- SN3Write a short note on acute HIV (primary) infection.